Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10 Clinical Trial Required)

Background
The National Cancer Institute (NCI) is issuing this Notice of Funding Opportunity (NOFO) to solicit applications for the maintenance of a Canadian Collaborating Clinical Trials Network as part of the NCI National Clinical Trials Network (NCTN).

The goal is to establish a full partnership with the U.S. Network in conducting large-scale, multi-site clinical trials that are relevant to both U.S. and Canadian cancer patient populations, while providing regulatory expertise and oversight for NCTN trials conducted in Canada.

Grant Details
The funding opportunity aims to support the Canadian Collaborating Clinical Trials Network (CCCTN) at Queen's University at Kingston, Ontario, Canada.

The CCCTN will be responsible for:
1. Administrative Core: Overseeing organizational and scientific management of the CCCTN.
2. Clinical Trial Development & Member Site Core: Providing expertise in clinical trial development and supporting patient accrual in Canada for NCTN trials.
3. Statistics and Data Management Core: Ensuring robust statistical analysis plans and data management for NCTN trials led by or involving the CCCTN.

Eligibility Requirements
Only Queen's University at Kingston, Ontario, Canada is eligible to apply for this funding opportunity. Other non-domestic entities may apply if they meet specific criteria outlined in the eligibility section.

Period of Performance
The total project period requested may not exceed 6 years, with specific timelines for application submission and project initiation detailed in the grant announcement.

Grant Value
The total value of the grant is anticipated to be $3.8 million for FY 2026, with one award expected to be made.

Place of Performance
The grant will be performed at Queen's University at Kingston, Ontario, Canada.